News

KaloBios Continues KB001-A Trial For Pseudomonas Aeruginosa Infection in Cystic Fibrosis, Despite Dissolution of Sanofi Licensing Deal

San Francisco based KaloBios Pharmaceuticals, Inc. on Monday released an update on the status of its KB001-A monoclonal antibody development program, including news that multinational Sanofi Pasteur, which had been collaborating with Kalobios on the KB001-A R&D program, is pulling out of the partnership. KaloBios will regain all…

Almost Half of CF Patients are Infected with Aspergillus Mold

According to a recent study conducted by a medical student from Manchester University in the United Kingdom, approximately 50 percent of cystic fibrosis patients are also infected by the Aspergillus fungus, which is caused by an exposure to mold. The research highlights the dangers of mold, and it may help doctors improve diagnosis…

Cats, Not Dogs, May Exacerbate Minor Cystic Fibrosis Symptoms

Cystic fibrosis-patient pet owners should have little concern over symptoms from their favorite “Fido,” but those with cuddly “Whiskers” may want to beware. A new study from the Eudowood Division of Pediatric Respiratory Sciences, Institute of Genetic Medicine, and Division of Pediatric Endocrinology in Johns Hopkins, published in…

Make-A-Wish and the Seattle Sounders Offer 18-year-old Cystic Fibrosis Patient an Experience as Professional Soccer Player

Xander Bailey is a 18-year-old cystic fibrosis patient who accomplished his dream last weekend thanks to the Make-A-Wish Foundation. The teen was added to the Seattle Sounders soccer team’s lineup and even started a friendly match against Tottenham Hotspur. The Make-A-Wish recipient from Greater Pennsylvania and West Virginia was given…